9. Oncol Rep 2008, 20:73743. 11. von Rosen A, Linder S, Harmenberg U, Pegert S

May 9, 2024

9. Oncol Rep 2008, 20:73743. 11. von Rosen A, Linder S, Harmenberg U, Pegert S: Serum levels of CA 19 and CA 50 in relation to Lewis blood cell status in individuals with malignant and benign pancreatic illness. Pancreas 1993, eight:16065. 12. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC Jr: ASCO 2006 update of recommendations for the usage of tumor markers in gastrointestinal cancer. J Clin Oncol 2006, 24:5313327. 13. Makawita S, Smith C, Batruch I, Zheng Y, R kert F, Gr zmann R, Pilarsky C, Gallinger S, Diamandis EP: Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol Cell Proteomics 2011, ten:M111.008599. 14. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, M ler M: pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinformatics 2011, 12:77.Makawita et al. BMC Cancer 2013, 13:404 http://www.biomedcentral/1471-2407/13/Page 11 of15. Katz MHG, Hwang R, Fleming JB, Evans DB: Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin 2008, 58:11125. 16. Brand RE, Nolen BM, Zeh HJ, Allen PJ, Eloubeidi MA, Goldberg M, Elton E, Arnoletti JP, Christein JD, Vickers SM, Langmead CJ, Landsittel DP, Whitcomb DC, Grizzle WE, Lokshin AE: Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res 2011, 17:80516. 17. Antonin W, Wagner M, Riedel D, Brose N, Jahn R: Loss from the zymogen granule protein syncollin affects pancreatic protein synthesis and transport but not secretion. Mol Cell Biol 2002, 22:1545554. 18. Williams JA: Regulation of pancreatic acinar cell function. Curr Opin Gastroenterol 2006, 22:49804. 19. Bach J-P, Borta H, Ackermann W, Faust F, Borchers O, Schrader M: The secretory granule protein syncollin localizes to HL-60 cells and neutrophils. J Histochem Cytochem 2006, 54:87788. 20. Gr borg M, Bunkenborg J, Kristiansen TZ, Jensen ON, Yeo CJ, Hruban RH, Maitra A, Goggins MG, Pandey A: Complete proteomic evaluation of human pancreatic juice. J Proteome Res 2004, three:1042055. 21. Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ, Pereira-Faca SR, Ireton RC, Katayama H, Glukhova V, Phanstiel D, Brenner DE, Anderson MA, Misek D, Scholler N, Urban ND, Barnett MJ, Edelstein C, Goodman GE, Thornquist MD, McIntosh MW, DePinho RA, Bardeesy N, Hanash SM: A mouse to human search for plasma proteome changes associated with pancreatic tumor improvement. PLoS Med 2008, five:e123. 22. Stanger BZ, Dor Y: Dissecting the cellular origins of pancreatic cancer. Cell Cycle 2006, five:436. 23. Schmid RM, Kl pel G, Adler G, Wagner M: Acinar-ductal-carcinoma sequence in transforming development factor-alpha transgenic mice.Streptozotocin supplier Ann N Y Acad Sci 1999, 880:21930.PARP1-IN-7 In stock 24.PMID:26760947 Lv S, Gao J, Zhu F, Li Z, Gong Y, Xu G, Ma L: Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets. Diagn Cytopathol 2011, 39:87581. 25. Jin CX, Hayakawa T, Ko SBH, Ishiguro H, Kitagawa M: Pancreatic stone protein/regenerating protein loved ones in pancreatic and gastrointestinal diseases. Intern Med 2011, 50:1507516. 26. Takayama R, Nakagawa H, Sawaki A, Mizuno N, Kawai H, Tajika M, Yatabe Y, Matsuo K, Uehara R, Ono K, Nakamura Y, Yamao K: Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma. J Gastroenterol 2010,.